NCT02073851View on ClinicalTrials.gov

DEFLECT II: A Study to Evaluate the Safety and Performance of the TriGuard™HDH in Patients Undergoing TAVR

NACompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

TriGuard™HDH

TriGuard™HDH Embolic Deflection Device in patients undergoing Transcatheter Aortic Valve Replacement (TAVR)

Trial Locations (1)

Unknown

UMC Utrecht, Utrecht

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Keystone Heart

INDUSTRY